Skip to main content
. 2021 Feb 25;16(2):e0246830. doi: 10.1371/journal.pone.0246830

Table 1. Demographic data and clinical characteristics of participants.

Variables Metabolic syndrome (n = 62) Control (n = 62) P-value
Age, mean ± SD, (years) 41.1 ± 7.0 38.3 ± 5.2 0.02*
Ethnicity, n (%) 0.078#
 Malay 26 (42%) 31 (57.1%)
 Chinese 19 (30.6%) 21 (33.3%)
 Indian 17 (27.4%) 10 (9.5%)
Male, n (%) 25 (40.3%) 25 (35.7%) 0.685#
BMI (kg/m2) 36.30 ± 6.83 22.71 ± 3.0 <0.001*
Systolic BP (mmHg) 141.4 ± 18.0 122.4 ± 8.0 <0.001*
Diastolic BP (mmHg) 82.0 ± 8.6 78.2 ± 2.6 0.001*
FBS (mmol/l) 7.1±2.5 4.7 ± 2.1 <0.001*
HbA1c (%) 7.64± 2.4 5.55 ± 0.38 <0.001*
HDL (mmol/l) 1.17 ±0.3 1.29±0.3 0.017*
Triglyceride (mmol/l) 1.83 ± 0.85 1.87 ± 0.22 0.77*
IOP (mmHg) 14.81 ± 1.91 14.96 ± 1.75 0.62*
Disc Area (mm) 2.17 ± 0.43 2.07 ± 0.35 0.162*
VCDR 0.55 ± 0.11 0.51 ± 0.14 0.05*
Axial length (mm) 24.34 ±0.46 24.36 ± 0.53 0.84*

* = unpaired t-test,

# = chi square,

BMI = body mass index, IOP = intraocular pressure, VCDR = vertical cup-to disc ratio, FBS = fasting blood sugar, HbA1c = glycated hemoglobin, HDL = high density lipoprotein.